Versant Capital Management’s Avidity Biosciences RNAM Stock Holding History

Versant Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-194	Closed	-$14K	–	2835
2025 Q4	$14K	Sell	194 -80	-29%	-$5.17K	﹤0.01%	1844
2025 Q3	$11.9K	Hold	274	–	–	﹤0.01%	1859
2025 Q2	$7.78K	Buy	274 +67	+32%	+$2K	﹤0.01%	1997
2025 Q1	$6.11K	Sell	207 -62	-23%	-$1.93K	﹤0.01%	1955
2024 Q4	$7.82K	Sell	269 -27	-9%	-$1.13K	﹤0.01%	1532
2024 Q3	$13.6K	Buy	+296	New	+$12.8K	﹤0.01%	953

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Versant Capital Management's RNAM Position: Q1 2026 in Review

Versant Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 194 shares — an estimated $14K sold.

Versant Capital Management first reported a position in RNAM in Q3 2024 and held it in 6 quarters. The position peaked at $14K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Versant Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Versant Capital Management sold 194 Avidity Biosciences shares in Q1 2026, an estimated $14K.
Versant Capital Management first reported a position in Avidity Biosciences in Q3 2024 and held it in 6 quarters.
Versant Capital Management's Avidity Biosciences position peaked at $14K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Versant Capital Management's 13F filing for Q1 2026, filed 7 Apr 2026.